Wang, Chao
Wang, Na
Jin, Yinghong
Liu, Rui
Ding, Yuanyuan
Zhang, Tao
Funding for this research was provided by:
Hebei Provincial Government Funded Outstanding Clinical Medicine Talent Program (Jicai Yu Fu [2022] No. 180)
Yulin City Science and Technology Major Special Project (YF-ZDZX-01-ZKT02)
Article History
Received: 4 December 2025
Revised: 17 January 2026
Accepted: 3 February 2026
First Online: 13 February 2026
Declarations
:
: This study was approved by the Ethics Committee of The First Affiliated Hospital of Xi’an Jiaotong University (Yulin Hospital) (Approval No. 2023034) and the Ethics Committee of the Second Affiliated Hospital of Xi’an Jiaotong University (Approval No. 2024141). All procedures involving human participants were performed in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants or their guardians prior to enrollment. Trial Registration: Chinese Clinical Trial Registry (ChiCTR2400082024, ChiCTR2400094130). The animal experiments were approved by the Biomedical Ethics Committee of the Health Science Center of Xi’an Jiaotong University (2022-1461).
: The animals used in this study were provided by Nanjing Detai Bioengineering Co., Ltd.
: All animal experimental procedures were conducted in accordance with the guidelines for the care and use of laboratory animals and were approved by the Biomedical Ethics Committee of the Medical School, Xi’an Jiaotong University (2022-1461).
: The authors declare no competing interests.